ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 133 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $84,728,000 | +74.8% | 4,492,466 | +9.1% | 1.58% | +90.3% |
| Q2 2019 | $48,478,000 | +176.0% | 4,118,806 | +220.1% | 0.83% | -14.3% |
| Q1 2019 | $17,564,000 | +52.5% | 1,286,748 | +14.5% | 0.97% | +27.6% |
| Q4 2018 | $11,519,000 | -23.6% | 1,123,813 | +24.1% | 0.76% | -20.8% |
| Q3 2018 | $15,072,000 | +25.7% | 905,254 | +19.3% | 0.96% | -6.5% |
| Q2 2018 | $11,992,000 | +34.8% | 758,964 | +8.4% | 1.02% | +16.0% |
| Q1 2018 | $8,896,000 | +2441.7% | 700,464 | +2189.1% | 0.88% | +2281.1% |
| Q4 2017 | $350,000 | -13.4% | 30,600 | -7.3% | 0.04% | -11.9% |
| Q3 2017 | $404,000 | +6.9% | 33,000 | 0.0% | 0.04% | -6.7% |
| Q2 2017 | $378,000 | -44.9% | 33,000 | 0.0% | 0.04% | -50.5% |
| Q1 2017 | $686,000 | 0.0% | 33,000 | 0.0% | 0.09% | -35.0% |
| Q4 2016 | $686,000 | -36.5% | 33,000 | 0.0% | 0.14% | -28.2% |
| Q3 2016 | $1,081,000 | +31.2% | 33,000 | 0.0% | 0.20% | +25.8% |
| Q2 2016 | $824,000 | +2.0% | 33,000 | 0.0% | 0.16% | +5.4% |
| Q1 2016 | $808,000 | – | 33,000 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,203 | $36,042,000 | 9.93% |
| Foresite Capital Management II, LLC | 1,043,832 | $12,787,000 | 5.18% |
| Redmile Group, LLC | 6,476,766 | $79,340,000 | 3.91% |
| DAFNA Capital Management LLC | 346,013 | $4,239,000 | 2.63% |
| Cormorant Asset Management, LP | 900,000 | $11,025,000 | 1.95% |
| SENZAR ASSET MANAGEMENT, LLC | 641,170 | $7,854,000 | 1.92% |
| Asymmetry Capital Management, L.P. | 105,228 | $1,289,000 | 1.50% |
| New Leaf Venture Partners, L.L.C. | 171,364 | $2,099,000 | 0.97% |
| EMERALD ADVISERS, LLC | 1,578,477 | $19,336,000 | 0.79% |
| BB BIOTECH AG | 2,266,008 | $27,759,000 | 0.77% |